Search Results - "Richieri, R."

Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental by Bennabi, D, Charpeaud, T, Yrondi, A, Genty, J-B, Destouches, S, Lancrenon, S, Alaïli, N, Bellivier, F, Bougerol, T, Camus, V, Dorey, J-M, Doumy, O, Haesebaert, F, Holtzmann, J, Lançon, C, Lefebvre, M, Moliere, F, Nieto, I, Rabu, C, Richieri, R, Schmitt, L, Stephan, F, Vaiva, G, Walter, M, Leboyer, M, El-Hage, W, Llorca, P-M, Courtet, P, Aouizerate, B, Haffen, E

“…Clear guidance for successive antidepressant pharmacological treatments for non-responders in major depression is not well established. Based on the RAND/UCLA…”
Get full text

High C-reactive protein levels are associated with depressive symptoms in schizophrenia by Faugere, M., Micoulaud-Franchi, J.-A., Faget-Agius, C., Lançon, C., Cermolacce, M., Richieri, R.

“…Depressive symptoms are frequently associated with schizophrenia symptoms. C - Reactive protein (CRP), a marker of chronic inflammation, had been found…”
Get full text

Quality of life is associated with chronic inflammation in schizophrenia: a cross-sectional study by Faugere, M, Micoulaud-Franchi, J A, Alessandrini, M, Richieri, R, Faget-Agius, C, Auquier, P, Lançon, C, Boyer, L

“…Inflammation may play a crucial role in the pathogenesis of schizophrenia. However, the association between chronic inflammation and health outcomes in…”
Get full text

Which antipsychotics should be chosen for the treatment of schizo-obsessive disorder? by Garosi, A, Richieri, R, Boyer, L, Lancon, C, Fond, G

Get more information

Risk factors for treatment resistance in unipolar depression: A systematic review by Bennabi, D, Aouizerate, B, El-Hage, W, Doumy, O, Moliere, F, Courtet, P, Nieto, I, Bellivier, F, Bubrovsky, M, Vaiva, G, Holztmann, J, Bougerol, T, Richieri, R, Lancon, C, Camus, V, Saba, G, Haesbaert, F, d’Amato, T, Charpeaud, T, Llorca, P.M, Leboyer, M, Haffen, E

“…Abstract Background Treatment resistant depression is a complex disorder and an important source of morbidity and mortality. Identification of risk factors of…”
Get full text

Hypovitaminosis D is associated with negative symptoms, suicide risk, agoraphobia, impaired functional remission, and antidepressant consumption in schizophrenia by Fond, G., Faugere, M., Faget-Agius, C., Cermolacce, M., Richieri, R., Boyer, L., Lançon, C.

“…Hypovitaminosis D has been associated with, respectively, major depressive disorder, schizophrenia (SZ), and cognitive disorders in the general population, and…”
Get full text

Depressive symptoms and chronic peripheral inflammation are associated with impaired functional remission in schizophrenia independently of psychotic remission by Fond, G, Faugere, M, Richieri, R, Cermolacce, M, Korchia, T, Micoulaud-Franchi, JA, Sunhary de Verville, PL, Boyer, L, Lançon, C

“…•Functional remission is the ultimate goal of schizophrenia care.•yet less than 20% of the stabilized patients succeed in reaching it.•in this study, we have…”
Get full text

Quality of life is associated with chronic inflammation in depression: A cross-sectional study by Faugere, M., Micoulaud-Franchi, J.-A., Faget-Agius, C., Lançon, C., Cermolacce, M., Richieri, R.

“…Inflammation may play a crucial role in the pathophysiology of depression. However, the association between chronic inflammation and health outcomes in…”
Get full text

Creating a new chapter in the DSM for late-onset depressive disorders by Gerolymos, C, Masson, M, Lancon, C, Richieri, R, Boyer, L, Fond, G

Get more information

ADHD and addictive behavior in crack-cocaine users by Fond, G, El-Maamar, M, Korchia, T, Richieri, R, Lacoste, J, Boyer, L, Lancon, C

“…Crack consumption is a major public health issue in Martinique with a poor prognosis. A preliminary study has found a high prevalence of history of childhood…”
Get more information

Adherence to treatment guidelines in clinical practice for using electroconvulsive therapy in major depressive episode by Samalin, L, Yrondi, A, Charpeaud, T, Genty, JB, Blanc, O, Sauvaget, A, Stéphan, F, Walter, M, Bennabi, D, Bulteau, S, Haesebaert, F, D'Amato, T, Poulet, E, Holtzmann, J, Richieri, RM, Attal, J, Nieto, I, El-Hage, W, Bellivier, F, Schmitt, L, Lançon, C, Bougerol, T, Leboyer, M, Aouizerate, B, Haffen, E, Courtet, P, Llorca, PM

“…•The level of adherence to guidelines for using ECT in depression was studied.•A mean duration of major depressive episode before ECT of about 10 months was…”
Get full text

Abnormal C-reactive protein blood levels as a specific biomarker of major depression and non-remission under antidepressants in schizophrenia by Fond, G., Micoulaud-Franchi, J.A., Faugere, M., Boyer, L., Faget-Agius, C., Lançon, C., Richieri, R., Cermolacce, M.

“…C-reactive protein (CRP) is a general marker of peripheral inflammation and has been shown to be a good marker of neuroinflammation. CRP has been found to be…”
Get full text

Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort by Andrianarisoa, M, Boyer, L, Godin, O, Brunel, L, Bulzacka, E, Aouizerate, B, Berna, F, Capdevielle, D, Dorey, J.M, Dubertret, C, Dubreucq, J, Faget, C, Gabayet, F, Llorca, P.M, Mallet, J, Misdrahi, D, Rey, R, Richieri, R, Passerieux, C, Schandrin, A, Tronche, A.M, Urbach, M, Vidailhet, P, Schürhoff, F, Fond, G

“…Abstract Objectives Depression and negative symptoms have been associated with impaired Quality of life (QoL) in schizophrenia (SZ). However, childhood trauma…”
Get full text

You get psychotropic drugs, so you don't need vaccination against Covid 19? by Fond, G, Masson, M, Richieri, R, Korchia, T, Lançon, C, Boyer, L

Get more information

Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort by Godin, O, Leboyer, M, Gaman, A, Aouizerate, B, Berna, F, Brunel, L, Capdevielle, D, Chereau, I, Dorey, J.M, Dubertret, C, Dubreucq, J, Faget, C, Gabayet, F, Le Strat, Y, Llorca, P.M, Misdrahi, D, Rey, R, Richieri, R, Passerieux, C, Schandrin, A, Schürhoff, F, Urbach, M, Vidalhet, P, Girerd, N, Fond, G

“…Abstract Objective Abdominal obesity was suggested to be a better predictor than Metabolic Syndrome (MetS) for cardiovascular mortality, however this is has…”
Get full text

The impact of parent history of severe mental illness on schizophrenia outcomes: results from the real-world FACE-SZ cohort by Garosi, A., Sunhary de Verville, P. L., Etchecopar-etchart, D., Richieri, R., Godin, O., Schürhoff, F., Berna, F., Aouizerate, B., Capdevielle, D., Chereau, I., Clauss-Kobayashi, J., Dorey, J. M., Dubertret, C., Coulon, N., Leignier, S., Mallet, J., Misdrahi, D., Passerieux, C., Rey, R., Szoke, A., Urbach, M., Leboyer, M., Llorca, P. M., Lançon, C., Boyer, L., Fond, G.

“…Parent history of severe mental illness (PHSMI) may have long-term consequences in adult offspring due to genetic and early environmental factors in…”
Get full text

Recommendations of the schizophrenia expert center network for the screening prevention and treatment of sleep disorders based on the results from the real-world schizophrenia FACE-SZ national cohort by Sunhary de Verville, P.L., Etchecopar-Etchart, D., Richieri, R., Godin, O., Schürhoff, F., Berna, F., Aouizerate, B., Capdevielle, D., Chereau, I., D'Amato, T., Dubertret, C., Dubreucq, J., Leignier, S., Mallet, J., Misdrahi, D., Passerieux, C., Pignon, B., Rey, R., Urbach, M., Vidailhet, P., Leboyer, M., Llorca, P.M., Lançon, C., Boyer, L., Fond, G.

“…Sleep disorders associated factors are under explored in schizophrenia while the literature suggests high and heterogeneous frequency. The objective of the…”
Get full text

The Covid-19 infection: An opportunity to develop systematic vitamin D supplementation in psychiatry by Fond, G, Masson, M, Richieri, R, Korchia, T, Etchecopar-Etchart, D, Sunhary de Verville, P-L, Lançon, C, Boyer, L

“…Psychiatric patients are at risk of hypovitaminosis D and Covid-19-related mortality. In addition to the mental health benefits, vitamin D supplementation may…”
Get more information

Redefining peripheral inflammation signature in schizophrenia based on the real-world FACE-SZ cohort by Fond, G., Sunhary de Verville, P.L., Richieri, R., Etchecopar-Etchart, D., Korchia, T., Faugere, M., Godin, O., Schürhoff, F., Berna, F., Aouizerate, B., Capdevielle, D., Chereau, I., Clauss-Kobayashi, J., Coulon, N., Dorey, J.M., Dubertret, C., Dubreucq, J., Mallet, J., Misdrahi, D., Passerieux, C., Pignon, B., Rey, R., Urbach, M., Leboyer, M., Llorca, P.M., Lançon, C., Boyer, L.

“…Peripheral inflammation is associated with impaired prognosis in schizophrenia (SZ). Highly sensitive C-reactive protein (hs-CRP) is the most used inflammatory…”
Get full text

Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set by Fond, Guillaume, Berna, F., Boyer, L., Godin, O., Brunel, L., Andrianarisoa, M., Aouizerate, B., Capdevielle, D., Chereau, I., Danion, J. M., Dubertret, C., Dubreucq, J., Faget, C., Gabayet, F., Le Gloahec, T., Llorca, P. M., Mallet, J., Misdrahi, D., Rey, R., Richieri, R., Passerieux, C., Portalier, C., Roux, P., Vehier, A., Yazbek, H., Schürhoff, F., Bulzacka, E.

“…Objective The effect of benzodiazepine long-term administration (BLTA) in cognitive functioning of subjects with schizophrenia (SZ) has been partially explored…”
Get full text